Markets › LSE › SN.L

Smith & Nephew plc

LSE:SN.LHealthcareFTSE:ASXFTSE:NMX

£10.87+0.79%At closeAt close · Tue 20 Oct · ≈ AED 53.17 · Market cap $12.18B · Next earnings Tue 23 Feb

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	4.6	5.2	5.2	5.5	5.8	6.3	+8.3%
Cost of revenue	1.4	1.5	1.5	1.7	1.8	2.0	+14.1%
Gross profit	3.2	3.7	3.7	3.8	4.0	4.3	+5.8%
Research & development	0.3	0.4	0.3	0.3	0.3	0.3	+4.6%
Selling, general & administrative	2.6	2.4	2.4	2.6	2.7	3.0	+11.4%
Selling & marketing	0.0	2.0	2.1	2.2	2.3	0.0	−100.0%
Operating expenses	2.9	3.1	3.2	3.4	3.4	3.3	−3.9%
Operating income	0.3	0.6	0.3	0.4	0.7	1.0	+55.9%
Interest expense	0.1	0.1	0.1	0.1	0.2	0.2	−5.2%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	+50.5%
Other income / expense	(0.0)	(0.0)	(0.1)	(0.1)	(0.2)	(0.2)	−43.8%
Pre-tax income	0.2	0.6	0.2	0.3	0.5	0.8	+59.7%
Income tax	(0.2)	0.1	0.0	0.0	0.1	0.2	+82.8%
Net income	0.4	0.5	0.2	0.3	0.4	0.6	+54.9%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	0.51	0.60	0.25	0.31	0.47	0.74	+57.4%
EPS, diluted (per share)	0.51	0.60	0.25	0.31	0.47	0.73	+55.3%
EBITDA	0.9	1.2	0.9	1.0	1.2	1.6	+30.1%
Depreciation & amortization	0.5	0.6	0.5	0.5	0.6	0.6	+0.9%
Weighted average shares (shares)	875,100,973	877,000,000	875,100,973	871,000,000	876,596,000	866,830,000	−1.1%
Weighted average diluted shares (shares)	875,100,973	877,721,943	875,100,973	873,000,000	876,596,000	872,893,000	−0.4%
Gross margin	69.4%	70.4%	70.5%	68.8%	69.6%	68.0%	−1.6 pts
Operating margin	6.5%	11.4%	6.0%	7.7%	11.3%	16.3%	+5.0 pts
Net margin	9.8%	10.1%	4.3%	4.7%	7.1%	10.1%	+3.0 pts